Fosfomycin: Clinical Trials

50 trials of Fosfomycin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 11 unknown, 9 recruiting, 4 terminated. 19 Phase 4, 11 Phase 3, 7 Phase 1, 5 Phase 2, 3 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 419Completed 8, Unknown 5, Recruiting 4, Terminated 2
Phase 311Completed 6, Recruiting 3, Terminated 1, Unknown 1
Phase 17Completed 5, Unknown 2
Phase 25Completed 3, Unknown 2
Not applicable3Completed 2, Unknown 1
Early Phase 12Terminated 1, Unknown 1

Follow Fosfomycin: new trials by email Literature Review of Fosfomycin trials Research Report on Fosfomycin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections
Ceftazidime± avibactam with fosfomycin, Ceftazidime± avibactam with placebo - Gram Negative Infections, Sepsis and Septic Shock
Phase 3RecruitingAngela HUTTNER1002025-08-252025-09-26
Optimising TREATment for Severe Gram-Negative Bacterial Infections
Colistin/Polymyxin B + Sulbactam, Colistin/Polymyxin B + Tigecycline/Eravacycline, Colistin/Polymyxin B + Meropenem - Bloodstream Infection, Ventilator Associated Bacterial Pneumonia
Phase 4RecruitingNational University of Singapore6002025-04-212025-06-04
IRONICA: IRON Repletion In Heart Failure - A Comparison of Oral and IV Approaches
Ferric Carboxymaltose, Ferrous Sulfate - Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF)
Phase 4TerminatedSyed Hamza Mufarrih422025-04-022026-07-20
Therapeutic Options for CRAB
Fosfomycin, Eravacycline, ampicillin/sulbactam - Infections, Bacterial, Sepsis Bacterial
Phase 4RecruitingClinical Hospital Centre Zagreb1082025-01-302026-01-21
COMPARISON OF NITROFURANTOIN WITH FOSFOMYCIN in TREATING CYSTITIS IN WOMEN
Nitrofurantoin 100 MG, Fosfomycin - Urinary Tract Infections
Phase 4UnknownShalamar Institute of Health Sciences3922025-01-012024-07-24
Fosfomycin Versus Standard of Care in Children With Antibiotic-resistant Urinary Tract Infections
Fosfomycin, Standard of care antibiotics - Urinary Tract Infections
Phase 3RecruitingUniversity of Sydney3002023-08-022024-06-06
Prevention of Iron Deficiency Anemia Post-delivery
Ferric carboxymaltose (FCM) and folic acid tablets, Oral iron tablets and folic acid tablets - Postpartum Anemia
Phase 3CompletedNICHD Global Network for Women's and Children's Health48572023-05-302026-07-01
Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection
Colistin Sodium Methanesulfonate, Colistin Sodium Methanesulfonate plus Fosfomycin - Infection Due to Carbapenem Resistant Acinetobacter
Phase 4UnknownChiang Mai University1882023-04-012024-08-26
Efficacy of Collagen, Propolis Plus Quercetin (Proqutin®), Bacillus Coagulans, Hyaluronic Acid and Chondroitin Sulphate and D-Mannose to Avoid Symptoms and Prevents Recurrence in Women With Recurrent Urinary Tract Infections
Fosfomycin 3 g, Uroxin 4G, Combination of dietary supplement and fosfomycin - Urinary Tract Infection (Diagnosis)
Phase 4CompletedUniversity of Campania Luigi Vanvitelli1482023-02-012024-10-26
Effectiveness of Single Dose Fosfomycin and Single Dose Levofloxacin as Pre-urodynamic Antibiotic for UTI Prevention
Fosfomycin 3000 MG, Levofloxacin 500mg - Urological System Complication of Procedure, Urinary Tract Infections
Phase 1 / Phase 2CompletedUniversitas Indonesia1262022-12-302024-10-09
Clinical Trial of Pivmecillinam Hydrochloride Tablets in the Treatment of Uncomplicated Urinary Tract Infection
Pivmecillinam hydrochloride tablets, Fosfomycin Tromethamine Granules - Uncomplicated Urinary Tract Infection
Phase 3CompletedBenova (Tianjin) Innovative medicine Research Co., Ltd.2992022-09-292024-04-17
Use of Prophylactic Antibiotics Prior to OnabotulinumtoxinA
Nitrofurantoin - Antibiotic Prophylaxis
Phase 4RecruitingAtlantic Health System1402022-08-162024-03-27
NextGen - Clinical Implication of Next Generation Sequencing
Antibiotic, Next Gen - Urinary Tract Infections
Phase 4RecruitingWake Forest University Health Sciences1002022-05-172025-12-08
Efficacy and Safety oF FErric CarboxymalTose in Patients With Advanced Gastric Cancer(EFFECT-AGC)
Ferinject, Conservative management - Advanced Gastric Carcinoma
Phase 3RecruitingAsan Medical Center3302022-04-292026-04-03
A Trial of Fosfomycin vs Ciprofloxacin for Febrile Neutropenia (FOVOCIP)
Fosfomycin, ciprofloxacin - Haematopoietic Stem Cell Transplantation, Acute Leukemia
Phase 3CompletedFundación para la Investigación Biosanitaria del Principado de Asturias1772022-03-142026-06-01
Effect of Cranberry Extract on the Urinary System
Fosfomycin, Cranberry - Urinary Tract Disease, Cystitis
CompletedKırklareli University22022-01-262022-03-02
Clinical Effectiveness and Bacteriological Eradication of 4 Short-course Antibiotics for Uncomplicated UTIs in Women.
Fosfomycin Trometamol Salt, Nitrofurantoin, Pivmecillinam - Urinary Tract Infections
Phase 4CompletedFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina10002021-11-022025-09-08
Bearberry in the Treatment of Cystitis
Fosfomycin, Bearberry - Cystitis
Not applicableUnknownUniversity of Pecs5042021-10-012021-09-24
EXtended Use of FOsfomycin for the Treatment of CYstitis in Primary Care
Fosfomycin, Nitrofurantoin - Urinary Tract Infections
Phase 3TerminatedMJM Bonten132021-09-062022-03-15
GM-CSF, Fosfomycin and Metronidazole for Pouchitis in Ulcerative Colitis Patients After Restorative IPAA Surgery
GM-CSF, fosfomycin and metronidazole - Pouchitis
Phase 1 / Phase 2UnknownZealand University Hospital182021-09-062023-01-26

Showing 20 of 50. Sign in to see all of them.

Conditions studied

Urinary Tract Infections (19)  ·  Cystitis (3)  ·  Heart Failure (3)  ·  Infections (3)  ·  Sepsis (3)  ·  Anemia, Iron-Deficiency (2)  ·  Arrhythmias, Cardiac (2)  ·  Bacterial Infections (2)  ·  Endocarditis (2)  ·  Hemophilia A (2)  ·  Hyperaldosteronism (2)  ·  Hypertension (2)  ·  Hypokalemia (2)  ·  Menorrhagia (2)  ·  Pain (2)

Sponsors

Nabriva Therapeutics AG (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  University Medical Center Goettingen (2)  ·  Ain Shams University (1)  ·  Angela HUTTNER (1)  ·  Asan Medical Center (1)  ·  Atlantic Health System (1)  ·  Azienda Ospedaliera di Lecco (1)  ·  Benova (Tianjin) Innovative medicine Research Co., Ltd. (1)  ·  Bionorica SE (1)  ·  Cardeas Pharma (1)  ·  Charite University, Berlin, Germany (1)  ·  Chiang Mai University (1)  ·  Clinical Hospital Centre Zagreb (1)  ·  Daniel Benjamin (1)

Countries

United States (14)  ·  Germany (7)  ·  Spain (6)  ·  Netherlands (4)  ·  Australia (3)  ·  China (3)  ·  Italy (3)  ·  Thailand (3)  ·  Turkey (Türkiye) (3)  ·  Canada (2)  ·  Denmark (2)  ·  France (2)  ·  Israel (2)  ·  Kenya (2)  ·  Mexico (2)

Top investigators

Eva Hummers-Pradier, Prof. Dr. (2)  ·  Andrej Trampuz, PD Dr (1)  ·  Andrej Trampuz, PD Dr. (1)  ·  Ann E. Stapleton, M.D. (1)  ·  Athitaya Luangnara (1)  ·  Carolyn Botros, DO (1)  ·  Chi Hornik (1)  ·  Chi Hornik, PharmD (1)  ·  David Seligson, MD (1)  ·  Eva Hummers-Pradier, Prof. (1)  ·  Evelyn J Ellis-Grosse, PhD (1)  ·  Florian Wagenlehner, Prof. (1)  ·  Harrina E Rahardjo, Professor (1)  ·  Heiman Wertheim, Prof. dr. (1)

Results publications

PMID 12011903, PMID 15276398, PMID 15840453, PMID 19588358, PMID 22530208, PMID 22742538, PMID 24614374, PMID 24891437, PMID 24949994, PMID 24982065, PMID 25048851, PMID 26039810, PMID 26698878, PMID 26926644, PMID 27522443, PMID 28095881, PMID 28137820, PMID 28290120, PMID 28339831, PMID 28779462, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 29710295, PMID 29891606, PMID 29970072, PMID 30051186, PMID 30133928, PMID 30231252, PMID 30790601, PMID 30853478, PMID 31317556, PMID 31548185, PMID 31767717, PMID 31814149, PMID 32029130, PMID 32324313, PMID 32331365, PMID 32497307, PMID 33029806, PMID 33413809, PMID 33560404, PMID 33855449, PMID 33903114, PMID 34111592, PMID 34302290, PMID 34824124, PMID 35046672, PMID 35065063

NIH funding

1UM1AI104681-01 (1)